Regulatory Affairs Management for Cell and Gene Therapy Market, Share & Trends Analysis Report, By Service Type (In-house Regulatory Affairs, Outsourced Regulatory Affairs), By Application (Oncology, Rare Diseases, Genetic Disorders, Other Applications), By Therapy Type, By Region, and Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Regulatory Affairs Management for Cell and Gene Therapy Market Snapshot Chapter 4. Global Regulatory Affairs Management for Cell and Gene Therapy Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034 4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.9. Use/impact of AI on Regulatory Affairs Management for Cell and Gene Therapy Market Industry Trends 4.10. Global Regulatory Affairs Management for Cell and Gene Therapy Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034 Chapter 5. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 1: By Service Type, Estimates & Trend Analysis 5.1. Market Share by Service Type, 2024 & 2034 5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Service Type: 5.2.1. In-house Regulatory Affairs 5.2.1.1. Regulatory Strategy Development 5.2.1.2. Clinical Trial Oversight 5.2.1.3. Post-Market Compliance 5.2.1.4. Policy Engagement 5.2.1.5. Others 5.2.2. Outsourced Regulatory Affairs 5.2.2.1. CMC Regulatory Affairs 5.2.2.2. Regulatory Consulting 5.2.2.3. Process Development Compliance 5.2.2.4. Specialized Submissions 5.2.2.5. Others Chapter 6. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 2: By Application, Estimates & Trend Analysis 6.1. Market Share by Application, 2024 & 2034 6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application: 6.2.1. Oncology 6.2.2. Rare Diseases 6.2.3. Genetic Disorders 6.2.4. Other Applications Chapter 7. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 3: By Therapy Type, Estimates & Trend Analysis 7.1. Market Share by Therapy Type, 2024 & 2034 7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapy Type: 7.2.1. Cell Therapy 7.2.2. Gene Therapy 7.2.3. Gene-Modified Cell Therapy Chapter 8. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. Global Regulatory Affairs Management for Cell and Gene Therapy Market, Regional Snapshot 2024 & 2034 8.2. North America 8.2.1. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.2.1.1. US 8.2.1.2. Canada 8.2.2. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034 8.2.3. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.2.4. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034 8.3. Europe 8.3.1. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.3.1.1. Germany 8.3.1.2. U.K. 8.3.1.3. France 8.3.1.4. Italy 8.3.1.5. Spain 8.3.1.6. Rest of Europe 8.3.2. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034 8.3.3. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.3.4. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034 8.4. Asia Pacific 8.4.1. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.4.1.1. India 8.4.1.2. China 8.4.1.3. Japan 8.4.1.4. Australia 8.4.1.5. South Korea 8.4.1.6. Hong Kong 8.4.1.7. Southeast Asia 8.4.1.8. Rest of Asia Pacific 8.4.2. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034 8.4.3. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.4.4. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034 8.5. Latin America 8.5.1. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.5.1.1. Brazil 8.5.1.2. Mexico 8.5.1.3. Rest of Latin America 8.5.2. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034 8.5.3. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.5.4. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034 8.6. Middle East & Africa 8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.6.1.1. GCC Countries 8.6.1.2. Israel 8.6.1.3. South Africa 8.6.1.4. Rest of Middle East and Africa 8.6.2. Middle East & Africa Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034 8.6.3. Middle East & Africa Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.6.4. Middle East & Africa Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Novartis AG 9.2.1.1. Business Overview 9.2.1.2. Key Service Type/Service Overview 9.2.1.3. Financial Performance 9.2.1.4. Geographical Presence 9.2.1.5. Recent Developments with Business Strategy 9.2.2. Amgen Inc. 9.2.3. Pfizer Inc. 9.2.4. Biogen Inc. 9.2.5. Gilead Sciences Inc. 9.2.6. Roche 9.2.7. Johnson & Johnson 9.2.8. Sanofi 9.2.9. Bayer AG 9.2.10. AstraZeneca PLC 9.2.11. Lonza Group Ltd. 9.2.12. Catalent, Inc. 9.2.13. Thermo Fisher Scientific Inc. 9.2.14. Charles River Laboratories International, Inc. 9.2.15. WuXi AppTec 9.2.16. IQVIA Holdings Inc. 9.2.17. Parexel International Corporation 9.2.18. Syneos Health, Inc. 9.2.19. PPD, Inc. 9.2.20. CMIC Group